Michael Rasche is the founder of Metabolon. Metabolon has raised $15M in total funding. Latest round: Series H. Backed by EW Healthcare Partners.
Michael Rasche joined Metabolon, a leader in metabolomics, as President of International Business in January 2019. In this role, he leads the company's international business activities, focusing on customer and team expansion. Metabolon is known for its Precision Metabolomics™ technology, which delivers biomarker discoveries, diagnostic tests, and data in genomics and population health. Rasche brings 28 years of experience in the healthcare and life science sectors, with a background in Pharma, Diagnostics, and Biotech, having held leadership positions at Definiens, Ayoxxa, Dako, Roche, and Bayer Diagnostics.
Full founder directory · Investor directory · Company funding database · Fundraising library